- Home
- AZ vs PACB Comparison
AZ vs PACB Comparison
Compare AZ & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZ
- PACB
- Stock Information
- Founded
- AZ 2018
- PACB 2000
- Country
- AZ Canada
- PACB United States
- Employees
- AZ N/A
- PACB N/A
- Industry
- AZ Industrial Machinery/Components
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- AZ Industrials
- PACB Industrials
- Exchange
- AZ Nasdaq
- PACB Nasdaq
- Market Cap
- AZ 319.5M
- PACB 381.5M
- IPO Year
- AZ N/A
- PACB 2010
- Fundamental
- Price
- AZ $8.54
- PACB $1.27
- Analyst Decision
- AZ Strong Buy
- PACB Buy
- Analyst Count
- AZ 1
- PACB 7
- Target Price
- AZ $20.00
- PACB $1.90
- AVG Volume (30 Days)
- AZ 205.5K
- PACB 6.8M
- Earning Date
- AZ 08-13-2025
- PACB 11-06-2025
- Dividend Yield
- AZ N/A
- PACB N/A
- EPS Growth
- AZ N/A
- PACB N/A
- EPS
- AZ N/A
- PACB N/A
- Revenue
- AZ $7,489,000.00
- PACB $156,110,000.00
- Revenue This Year
- AZ $1,343,857.60
- PACB $5.26
- Revenue Next Year
- AZ N/A
- PACB $16.13
- P/E Ratio
- AZ N/A
- PACB N/A
- Revenue Growth
- AZ 19.04
- PACB N/A
- 52 Week Low
- AZ $1.38
- PACB $0.85
- 52 Week High
- AZ $12.36
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- AZ 38.02
- PACB 45.49
- Support Level
- AZ $8.45
- PACB $1.20
- Resistance Level
- AZ $9.82
- PACB $1.33
- Average True Range (ATR)
- AZ 0.57
- PACB 0.07
- MACD
- AZ -0.03
- PACB -0.00
- Stochastic Oscillator
- AZ 15.13
- PACB 35.00
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.